IL-18 can trigger atherosclerosis-relevant IFNγ expression even in the absence of T cells, as the administration of recombinant IL-18 to lymphocyte-deficient SCID mice led to increased lesion size accompanied by elevated IFNγ levels in the circulation [29]. Here, IL18 is linked to atherosclerosis.